{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:51:31Z","timestamp":1791154291472,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Impaired T-cell reactivity is a feature of C3-deficient mice in several disease models. The mechanism behind the reduced T-cell response is, however, poorly understood. We explored the hypothesis that antigen-presenting cells (APCs) from C3-\/- mice have impaired potency to stimulate antigen-specific T cells, in an alloantigen-dependent model. Our results show that C3-\/- macrophages have reduced ability to elicit alloreactive T-cell responses in vitro and in vivo, affecting both the primary and secondary responses. The C3 status of donor macrophages had a major impact on the CD4 T-cell response. The impaired CD4 T-cell response was associated with reduced expression of MHC class II on the surface of C3-\/- macrophages, without loss of class II gene expression. Furthermore, inhibition of C3 gene expression in C3+\/+ macrophages reduced their ability to stimulate alloreactive T cells, suggesting that endogenous production of C3 could in part contribute to the potency of APCs. Our data provide compelling evidence that C3 deficiency modulates the potency of APCs to stimulate the T-cell response, suggesting a critical role for complement in the maintenance of APC function. This could offer a partial explanation as to why the T-cell response is impaired in C3-\/- mice. (Blood. 2006;107:2461-2469)<\/jats:p>","DOI":"10.1182\/blood-2005-08-3144","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T01:44:43Z","timestamp":1132710283000},"page":"2461-2469","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":73,"title":["Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells"],"prefix":"10.1182","volume":"107","author":[{"given":"Wuding","family":"Zhou","sequence":"first","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetal","family":"Patel","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Bernadette","family":"Villiers","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Sacks","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Transplantation, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, United Kingdom; and the Laboratoire d'Immunochimie, Commissariat a\u0300 l'Energie Atomique de Grenoble (CEA-G), De\u0301partement Re\u0301ponse et Dynamique Cellulaire\/Immunochimie (DRDC\/ICH), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U548, Universite\u0301 J. Fourier, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111711492291400_REF1","doi-asserted-by":"crossref","unstructured":"Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med.2000;343: 338-344.","DOI":"10.1056\/NEJM200008033430506"},{"key":"2019111711492291400_REF2","unstructured":"Walport MJ. Complement. First of two parts. N Engl J Med.2001;344: 1058-1066."},{"key":"2019111711492291400_REF3","unstructured":"Walport MJ. Complement. Second of two parts. N Engl J Med.2001;344: 1140-1144."},{"key":"2019111711492291400_REF4","doi-asserted-by":"crossref","unstructured":"Alper CA, Johnson AM, Birtch AG, Moore FD. Human C\u20323: evidence for the liver as the primary site of synthesis. Science.1969;163: 286-288.","DOI":"10.1126\/science.163.3864.286"},{"key":"2019111711492291400_REF5","doi-asserted-by":"crossref","unstructured":"Colten HR, Strunk RC, Perlmutter DH, Cole FS. Regulation of complement protein biosynthesis in mononuclear phagocytes. Ciba Found Symp.1986;118: 141-154.","DOI":"10.1002\/9780470720998.ch10"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Botto M, Lissandrini D, Sorio C, Walport MJ. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol.1992;149: 1348-1355.","DOI":"10.4049\/jimmunol.149.4.1348"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Brooimans RA, Stegmann AP, van Dorp WT, et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest.1991;88: 379-384.","DOI":"10.1172\/JCI115314"},{"key":"2019111711492291400_","unstructured":"Sacks SH, Zhou W, Pani A, Campbell RD, Martin J. Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology.1993;79: 348-354."},{"key":"2019111711492291400_REF9","doi-asserted-by":"crossref","unstructured":"Sheerin NS, Zhou W, Adler S, Sacks SH. TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int.1997;51: 703-710.","DOI":"10.1038\/ki.1997.101"},{"key":"2019111711492291400_REF10","doi-asserted-by":"crossref","unstructured":"Colten HR, Garnier G. Regulation of complement protein gene expression. In: Volanakis JE, Frank MM, eds. The Human Complement System in Health and Disease. New York, NY: Marcel Dekker; 1998: 217-240.","DOI":"10.1201\/b14212-11"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Andrews PA, Zhou W, Sacks SH. Tissue synthesis of complement as an immune regulator. Mol Med Today.1995;1: 202-207.","DOI":"10.1016\/S1357-4310(95)91951-1"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Zhou W, Marsh JE, Sacks SH. Intrarenal synthesis of complement. Kidney Int.2001;59: 1227-1235.","DOI":"10.1046\/j.1523-1755.2001.0590041227.x"},{"key":"2019111711492291400_REF13","doi-asserted-by":"crossref","unstructured":"Sacks SH, Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant.2003;3: 927-932.","DOI":"10.1034\/j.1600-6143.2003.00175.x"},{"key":"2019111711492291400_REF14","doi-asserted-by":"crossref","unstructured":"Botto M, Walport MJ. Hereditary deficiency of C3 in animals and humans. Int Rev Immunol.1993;10: 37-50.","DOI":"10.3109\/08830189309051170"},{"key":"2019111711492291400_REF15","doi-asserted-by":"crossref","unstructured":"Singer L, Colten HR, Wetsel RA. Complement C3 deficiency: human, animal, and experimental models. Pathobiology.1994;62: 14-28.","DOI":"10.1159\/000163873"},{"key":"2019111711492291400_REF16","doi-asserted-by":"crossref","unstructured":"Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science.1996;271: 348-350.","DOI":"10.1126\/science.271.5247.348"},{"key":"2019111711492291400_REF17","doi-asserted-by":"crossref","unstructured":"Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol.2004;5: 981-986.","DOI":"10.1038\/ni1113"},{"key":"2019111711492291400_REF18","doi-asserted-by":"crossref","unstructured":"Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med.2002;8: 373-378.","DOI":"10.1038\/nm0402-373"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Suresh M, Molina H, Salvato MS, et al. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol.2003;170: 788-794.","DOI":"10.4049\/jimmunol.170.2.788"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Kaya Z, Afanasyeva M, Wang Y, et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol.2001;2: 739-745.","DOI":"10.1038\/90686"},{"key":"2019111711492291400_REF21","doi-asserted-by":"crossref","unstructured":"Marsh JE, Farmer CK, Jurcevic S, et al. The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation.2001;72: 1310-1318.","DOI":"10.1097\/00007890-200110150-00022"},{"key":"2019111711492291400_REF22","unstructured":"Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology.1995;84: 164-170."},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Rey-Millet CA, Chesne S, Colomb MG. Associated complement C3b: towards an understanding of its intracellular modifications. Mol Immunol.1993;30: 855-864.","DOI":"10.1016\/0161-5890(93)90009-Z"},{"key":"2019111711492291400_REF24","doi-asserted-by":"crossref","unstructured":"Serra VA, Cretin F, Pepin E, Gabert FM, Marche PN. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production. Eur J Immunol.1997;27: 2673-2679.","DOI":"10.1002\/eji.1830271029"},{"key":"2019111711492291400_REF25","doi-asserted-by":"crossref","unstructured":"Wessels MR, Butko P, Ma M, et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A.1995;92: 11490-11494.","DOI":"10.1073\/pnas.92.25.11490"},{"key":"2019111711492291400_","doi-asserted-by":"crossref","unstructured":"Fischer MB, Ma M, Goerg S, et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol.1996;157: 549-556.","DOI":"10.4049\/jimmunol.157.2.549"},{"key":"2019111711492291400_REF27","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Fukuda W, Circolo A, et al. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A.1997;94: 8720-8725.","DOI":"10.1073\/pnas.94.16.8720"},{"key":"2019111711492291400_REF28","unstructured":"Davies JQ, Gordon S. Isolation and culture of murine macrophages. Methods Mol Biol.2005;290: 91-103."},{"key":"2019111711492291400_REF29","doi-asserted-by":"crossref","unstructured":"Van den Berg CW, Van Dijk H, Capel PJ. Rapid isolation and characterization of native mouse complement components C3 and C5. J Immunol Methods.1989;122: 73-78.","DOI":"10.1016\/0022-1759(89)90336-0"},{"key":"2019111711492291400_REF30","doi-asserted-by":"crossref","unstructured":"Hong Y, Zhou W, Li K, Sacks SH. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int.2002;62: 1291-1300.","DOI":"10.1111\/j.1523-1755.2002.kid586.x"},{"key":"2019111711492291400_REF31","doi-asserted-by":"crossref","unstructured":"Kerekes K, Prechl J, Bajtay Z, Jozsi M, Erdei A. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol.1998;10: 1923-1930.","DOI":"10.1093\/intimm\/10.12.1923"},{"key":"2019111711492291400_REF32","doi-asserted-by":"crossref","unstructured":"Erdei A, Kohler V, Schafer H, Burger R. Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens. Immunobiology.1992;185: 314-326.","DOI":"10.1016\/S0171-2985(11)80649-2"},{"key":"2019111711492291400_REF33","doi-asserted-by":"crossref","unstructured":"Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol.2002;169: 5926-5933.","DOI":"10.4049\/jimmunol.169.10.5926"},{"key":"2019111711492291400_REF34","doi-asserted-by":"crossref","unstructured":"Hopken UE, Lu B, Gerard NP, Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature.1996;383: 86-89.","DOI":"10.1038\/383086a0"},{"key":"2019111711492291400_REF35","doi-asserted-by":"crossref","unstructured":"Quigg RJ, Kozono Y, Berthiaume D, et al. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol.1998;160: 4553-4560.","DOI":"10.4049\/jimmunol.160.9.4553"},{"key":"2019111711492291400_REF36","unstructured":"Nicol PA, Lachmann PJ. The alternate pathway of complement activation: the role of C3 and its inactivator (KAF). Immunology.1973;24: 259-275."},{"key":"2019111711492291400_REF37","doi-asserted-by":"crossref","unstructured":"Pangburn MK, Muller-Eberhard HJ. The alternative pathway of complement. Springer Semin Immunopathol.1984;7: 163-192.","DOI":"10.1007\/BF01893019"},{"key":"2019111711492291400_REF38","doi-asserted-by":"crossref","unstructured":"Takabayashi T, Shimizu S, Clark BD, et al. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells. Surgery.2004;135: 544-554.","DOI":"10.1016\/j.surg.2003.09.010"},{"key":"2019111711492291400_REF39","doi-asserted-by":"crossref","unstructured":"Imagawa DK, Osifchin NE, Ramm LE, et al. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J Immunol.1986;136: 4637-4643.","DOI":"10.4049\/jimmunol.136.12.4637"},{"key":"2019111711492291400_REF40","doi-asserted-by":"crossref","unstructured":"Yaskanin DD, Waxman FJ. Expression of the CR1 receptor on human leukemia-derived CD4+ T cell lines. Cell Immunol.1995;163: 139-147.","DOI":"10.1006\/cimm.1995.1108"},{"key":"2019111711492291400_REF41","doi-asserted-by":"crossref","unstructured":"Wagner C, Hansch GM, Stegmaier S, et al. The complement receptor 3, CR3 (CD11b\/CD18), on T lymphocytes: activation-dependent upregulation and regulatory function. Eur J Immunol.2001;31: 1173-1180.","DOI":"10.1002\/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9"},{"key":"2019111711492291400_REF42","doi-asserted-by":"crossref","unstructured":"McPhaden AR, Whaley K. Complement biosynthesis by mononuclear phagocytes. Immunol Res.1993;12: 213-232.","DOI":"10.1007\/BF02918254"},{"key":"2019111711492291400_REF43","unstructured":"Arvieux J, Yssel H, Colomb MG. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology.1988;65: 229-235."},{"key":"2019111711492291400_REF44","unstructured":"Zhou W, Song L, Patel H, et al. Endogenous C3 expression affects the potency of macrophages as stimulators of T cell alloreactivity. Molecular Immunology.2004;41: 332."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/6\/2461\/1286526\/zh800606002461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/6\/2461\/1286526\/zh800606002461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T15:23:48Z","timestamp":1683300228000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/6\/2461\/22083\/Macrophages-from-C3deficient-mice-have-impaired"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3144","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}